The bacterial infection of chorion and amnion is a common finding in premature delivery and is referred to as chorioamnionitis. As the mother rarely shows symptoms of a systemic inflammation, the course of chorioamnionitis is frequently asymptomatic and chronic. In contrast, the fetal inflammatory response syndrome represents a separate phenomenon, including umbilical inflammation and increased serum levels of proinflammatory cytokines in the fetus. Ascending maternal infections frequently lead to systemic fetal inflammatory reaction. Clinical studies have shown that antenatal exposure to inflammation puts the extremely immature neonates at a high risk for worsening pulmonary, neurological and other organ development. Interestingly, the presence of chorioamnionitis is associated with a lower rate of neonatal mortality in extremely immature newborns. In the following review, the pathogeneses of inflammation-associated perinatal morbidity are outlined. The concept of fetal multiorganic disease during intrauterine infection is introduced and discussed.
Introduction
Despite substantial progress in antenatal care, preterm birth remains a major health issue across the globe. In the Western world, preterm birth accounts for 5 to 13% of all live births, with important regional differences. 1 The incidence of preterm birth continues to rise steadily, exposing the society to increasing medical and social expenses. 1 Roughly, the causes of preterm birth can be divided into two groups: indicated preterm birth and preterm birth preceded by spontaneous preterm labor or preterm prelabor rupture of membranes (PPROM). Obviously, in the former group the direct cause is iatrogenic and may relate to fetal or maternal indications for intervention. These include severe intrauterine growth retardation, and maternal pre-eclampsia and hypertension, elevated liver enzymes, low platelets (HELLP) syndrome. On the other hand, preterm deliveries in the larger group of spontaneous preterm labor and PPROM are often associated with intrauterine inflammation or chorioamnionitis. 1, 2 A close association between chorioamnionitis and spontaneous preterm delivery exists. 2 As a result, the proportion of preterm infants exposed to chorioamnionitis increases with decreasing gestational age to up to 80% below 28 weeks of gestation. 3, 4 Ascending bacterial invasion of the uterine cavity is thought to be the most common route of infection, although bacteria are identified only in the minority of cases. 2 Organisms most frequently associated with chorioamnionitis are mainly of low virulence, including Ureaplasma spp. and Mycoplasma spp. 2, 5 Both the maternal and fetal immune system have an important role in chorioamnionitis, given the shown associations between polymorphisms in immunoregulatory genes and the risk of chorioamnionitis and preterm labor. 6, 7 A large subset of chorioamnionitis cases remain clinically silent. These may be diagnosed by culture or proteomic profiling of the amniotic fluid, by microbial culture or footprinting, or by histological examination of the placenta after birth. 5 The latter is generally regarded as the 'gold standard' in the diagnosis of chorioamnionitis. 5 More serious cases of chorioamnionitis may become clinically apparent and cause both general (fever, leukocytosis and raised C-reactive protein) and local symptoms (uterine tenderness and vaginal discharge). Although a combination of these symptoms is often given the syndromic description 'clinical chorioamnionitis', the overlap with the histological diagnosis of chorioamnionitis has been shown to be only modest. 8 In chorioamnionitis, the presence of fetal signs of inflammation, such as funisitis or elevated cord blood interleukin-6 (IL-6), is thought to reflect the more serious side of the continuum. 9 When intrauterine inflammation is present, the fetus may be exposed through direct contact with amniotic fluid or through the placental-fetal circulation. The consequent fetal response to chorioamnionitis has been referred to as the fetal inflammatory response syndrome (FIRS). 9 Many studies have associated chorioamnionitis with adverse neonatal outcome in newborn infants and the most pronounced effects were often present in infants with signs of FIRS. Although earlier studies have focused mainly on the respiratory and neurological outcomes, additional fetal sequelae of chorioamnionitis have more recently been described in several other organ systems. Moreover, evidence is increasing that the effects of chorioamnionitis on health and disease may extend well beyond the neonatal period. 10 In the current review we aim to give an overview on the concept of chorioamnionitis as a multiorgan disease of the fetus, and discuss potential long-term consequences and therapeutic options for early intervention.
Multiorgan overview
Brain Clinical observations. Specific stages of brain development could be affected at different gestational ages with different prognoses that manifest throughout the entire lifespan. In term and preterm newborns in particular, perinatal brain damage is a fundamental cause of developmental delay and lifelong neurological disabilities, such as mental retardation, cerebral palsy as well as school and behavioral difficulties. In addition, perinatal brain injury might increase the risk for the development of psychiatric disorders such as schizophrenia later in life. 11 Chorioamnionitis and vasculitis in the umbilical cord (funisitis) have a high incidence in preterm deliveries and are probably the most important risk factor of both preterm labor and birth, and preterm cerebral white matter disease (WMD) (Figure 1) . Furthermore, hypoxia-ischemia in association with chorioamnionitis markedly increases the vulnerability of the immature brain to the deficits mentioned above. 12 Diffuse or focal WMD, usually described as periventricular leukomalacia, has been shown to be the predominant feature of brain damage in premature newborns of <32 weeks of gestation. 11 Magnetic resonance imaging studies at corrected term age showed that 21% of extreme preterm infants have moderate-to-severe WMD, and this was predictive of cerebral palsy at the corrected age of 2 years. 13 In clinical studies, antenatal exposure to inflammation has been associated with an increased risk for periventricular leukomalacia and cerebral palsy. [14] [15] [16] Moreover, neurodevelopmental delay has been linked with previous exposure to chorioamnionitis by some studies, although others have failed to reproduce these findings. 10 Animal experimental evidence. Experimentally, inflammatory processesFinduced by intra-amniotic or intravenous fetal endotoxin administrationFimpair myelination. 17 We showed Figure 1 Chorioamnionitis as a multiorgan disease of the fetus. The fetus is being exposed to contaminated amniotic fluid that is aspirated and/or slicked by the fetus. The direct and indirect exposure has been associated with effects on several organs that are depicted in the figure.
global central nervous system compromise after chorioamnionitis induced by the intra-amniotic administration of lipopolysaccharide (LPS) in the fetal sheep. 18 Chorioamnionitis induced microglial activation, astrogliosis and apoptotic cell death and differentially affected the whole ovine central nervous system. Regional responses varied as a function of its maturational stage; for example, brain and cerebellar, but not spinal premyelinating oligodendrocytes, were found to be vulnerable at the gestational age of 125 days (term being 150 days). 18 In addition, Garnier et al. 19 showed microglial activation in the periventricular and subcortical white matter and increased S100B protein blood levels in a model of intravenous fetal LPS administration at a gestational age of 107 days.
The activated microglia have a central role in the pathogenesis of WMD. Inflammation-mediated impairment of oligodendrocyte progenitor cell development into myelinating, mature oligodendrocytes is mainly caused by the influence of the native activated microglia. 20 The activated microglia in the diffuse white matter lead to the apoptotic death of the developing oligodendrocytes by two mechanisms. First, in addition to the systemic upregulated proinflammatory cytokines, the diffuse microglial production of proinflammatory cytokines, for example, tumor necrosis factor-a (TNF-a), IL-1, IL-6 and interferon-g, affects mainly the cerebral fetal white matter oligodendrocytes, 18 and secondarily induces neuronal loss and impaired neuronal guidance, 21 with high levels of proinflammatory cytokines.
22
Although low cytokine levels are crucial for the maturation and differentiation of oligodendrocyte precursors into myelinating mature oligodendrocytes, high levels of proinflammatory cytokines, as found in inflamed fetal brains, inhibit this process. 23, 24 In addition, proinflammatory cytokines may affect the central nervous system by increasing the permeability of the developing blood brain barrier exclusively observed in the cerebral white matter, 25 and by impairing the cerebral blood flow. 26 Second, developing oligodendrocytes are injured by reactive oxygen species and reactive nitrogen species generated by either oligodendrocyte glutamatergic excitotoxicity or microglial activation. The activated microglia generate free radicals and induce the ultimate death of the antioxidant-deficient immature oligodendrocytes. 27 Combined, these two processes result in morphological white matter lesions and the impairment of myelination, one of the most serious complications of WMD in preterm infants. 28 Pathogenetically important is the fact that the immature fetal brain becomes sensitized to hypoxia-ischemia during antenatal infection. There is a sensitization of the fetal brain to a subsequent hypoxic-ischemic insult after intraperitoneal or intracisternal application of bacterial endotoxins. 29, 30 Here also, premyelinating oligodendrocyte injury takes place. In addition to a reduction in myelination, this leads to a secondary loss of small volumes of brain cortical and deep gray matter. 21 This observation is of great clinical relevance as a fetal inflammatory response is frequently associated with perinatal hypoxia-ischemia. 11 Recently, a new effect of neuroinflammation was revealed. Neuroinflammation is not only neurotoxic, as already shown, but may also be beneficial for neural repair. 31 For instance, TNF-a might lead to structural repair through the upregulation of astroglial brain-derived neurotrophic factor 31 and macrophages can be involved in optic axonal regeneration. 32 Furthermore, LPSinduced sublethal inflammation may affect developing central nervous system vulnerability, offering neuroprotection to a severe hypoxic-ischemic insult in the 7-day-old rat. This preconditioning by LPS is associated with upregulation of endogenous corticosterone and with cerebral gene regulation and merits further research. 33 Eye Retinopathy of prematurity (ROP) is a disease of the eye that affects prematurely born infants. It is a disorganized growth of retinal blood vessels that may result in scarring and retinal detachment ( Figure 1 ). ROP may be mild and often resolves spontaneously, but it may lead to blindness in serious cases. Both oxygen toxicity and relative hypoxia can contribute to its development. An association with chorioamnionitis was shown by several groups. [34] [35] [36] [37] [38] [39] Moreover, chorioamnionitis correlated positively with severity of ROP in a recent study, 39 an effect that was only partly attributable to a lower gestational age. Currently, low gestational age and both prenatal and postnatal inflammatory mechanisms often co-occur and seem to contribute importantly to the development of ROP. 39 Thyroid Thyroid hormones are required for normal development of the brain. Transient hypothyroxinemia of prematurity is the most common thyroid dysfunction in preterm infants and is defined by temporary low levels of T4, T3, and normal or low thyroid-stimulating hormone ( Figure 1 ). Low T4 levels in preterm infants are associated with persistent neurodevelopmental deficits in cognitive and motor function. 40 De Felice et al. 41 tested the hypothesis that transient hypothyroxinemia of prematurity was associated with histological chorioamnionitis and showed a previously unrecognized relationship with chorioamnionitis.
Thymus
Recent evidence indicates that chorioamnionitis is associated with a significant decrease in thymic size because of an acute thymic involution in very low birth weight preterm infants ( Figure 1 ). Although fetal thymus size is decreased in women with PPROM and chorioamnionitis, the measurement of the fetal thymus (for example, using ultrasound) might give additional information in subclinical cases. 42, 43 Di Naro et al. 44 suggested that fetal thymus involution in preterm labor patients was strongly associated with funisitis, as the histological manifestation of the FIRS. In addition, significant morphological changes are present in the thymus that include increased organ complexity, severe reduction of thymocytes, and monocytic and macrophagic infiltration of Hassall's bodies. 45 We have shown using the model of endotoxin-induced chorioamnionitis how the induction of a fetal inflammatory response resulted in changes in the thymus composition with respect to CD4-, CD8-and CD4/CD25-positive T lymphocytes. The latter T lymphocytes are regulatory T lymphocytes that have a major role in the initiation and resolution of inflammation. 46 The relevance of these changes for postnatal life remains to be shown.
Lungs
Clinical observations. Preterm birth is highly associated with respiratory distress syndrome (RDS), caused by structural and functional immaturity of the newborn lung. A modulating role of intrauterine exposure on lung immaturity has been recognized for many years 47 ( Figure 1 ). Watterberg et al. 48 were the first to show an intriguing ambivalent association between chorioamnionitis and respiratory morbidity. In ventilated preterm infants they were able to show a decrease in RDS but a subsequent increase in chronic lung injury (bronchopulmonary dysplasia (BPD)) after chorioamnionitis. 48 Many studies since then have reproduced the association between intrauterine inflammation and decreased RDS incidence, as reviewed recently. 47 Fetal signs of chorioamnionitis have been shown to have an additional effect on RDS reduction, suggesting a 'dose'-dependent response. 4 However, we have not been able to reproduce these findings. 8 Despite a reduction in acute respiratory problems, several early human studies have shown chorioamnionitis to be associated with a paradoxical increase in chronic lung disease of prematurity. 47, 48 However, more recent studies show considerable heterogeneity regarding this association. 47 Part of the inconsistency among studies may be explained by the imprecise diagnosis of both RDS and BPD. Moreover, several confounders affect the relationship between chorioamnionitis and BPD. The most obvious one is gestational age, which is inversely correlated with the incidence of both entities. Thus, chorioamnionitis-exposed infants may be at a higher risk for BPD merely because of their lower gestational age. However, recent epidemiological studies give an intriguing additional explanation and support a 'secondary hit' hypothesis. In these particular studies, chorioamnionitis was associated with a decreased rather than increased risk for BPD in preterm infants. 3, 49 On one hand, the effect was reversed when adjusted for mechanical ventilation, 3, 50 and on the other, chorioamnionitis-exposed infants who were mechanically ventilated for more than a week were at an increased risk of BPD. 49 We have recently shown that alveolar epithelial repair mechanisms are less effective in ventilated preterm infants with chorioamnionitis, providing a potential underlying mechanism for the above mentioned association. 51 In addition, postnatal sepsis also highly increased BPD risk in infants with chorioamnionitis in both studies. 3, 49 Recently, we provided evidence for a potential role of reduced surfactant efficacy in infants with severe chorioamnionitis, associated with increased BPD susceptibility. 52 These observations suggest that after intrauterine inflammation, preterm lungs are more susceptible to secondary injury, leading to chronic lung disease. Clearly, additional studies are needed to investigate this complex association (Figure 2) .
Although there is now compelling evidence that chorioamnionitis affects lung development and neonatal pulmonary outcome, little is known about the effects in term newborns and beyond the neonatal period (Figure 1 ). One small study reported an association between chorioamnionitis and severe pulmonary hypertension, as measured by nitric oxide use. 53 Follow-up data are available from two studies. 54, 55 In a trial of postnatal hydrocortisone, chorioamnionitis was not associated with changes in the use of supplemental oxygen, bronchodilators or steroids at 18 to 22 months. 54 However, Kumar et al. 55 recently reported an association between chorioamnionitis and both recurrent wheezing and physician-diagnosed asthma. This suggests that intrauterine exposure to inflammation may indeed have long-term adverse respiratory effects. 10 Animal experimental evidence: maturation and injury. Clinical observations have generated the concept that antenatal exposure to inflammation may have positive and/or negative effects on preterm lung function and development. 47, 56 However, the presence of chorioamnionitis may be an underlying factor that is modulated by additional factors in its importance for clinical outcomes such as RDS and BPD. The role of mechanical ventilation for the development of BPD in the presence of chorioamnionitis has been highlighted above. Ruptured membranes as surrogate for fetal infection, high concentrations of IL-6 in the cord blood as a sign for systemic inflammation 57 and colonization with Ureaplasma spp. 58 all independently predict a low risk for RDS. However, the Alabama Preterm Birth study further differentiated between the effects of histological chorioamnionitis (as reducing the risk of RDS) and the presence of ureaplasma/mycoplasma-positive cord blood cultures (as having no effect on RDS). 59 Given the complexity of clinical exposures in duration and bacterial agents, animal models are useful to study how fetal exposure to inflammation affects the fetal lung. Bry et al. 60 discovered that the intra-amniotic injection of IL-1 improved lung pressure-volume curves and induced mRNA for the surfactant proteins in rabbit fetuses. Sheep have been used to overcome the relative short period of gestation in small animals. Intra-amniotic injections of LPS from Escherichia coli and IL-1 caused inflammation of the chorioamnion and amniotic fluid with increased cell numbers and cytokine concentrations. [61] [62] [63] The indicators of inflammation were also increased in the fetal lung within 5 h and recruitment of neutrophils into the fetal airways was detected within 12 h. 64 The cytokines and inflammatory cells reached their peak after 3 days. The injury to the epithelium of the fetal lung resulted in a permeability defect and apoptosis followed by an increase in proliferation during resolution. 64, 65 This injury response was accompanied by an increase of surfactant protein mRNAs, 62, 63 thinning of alveolar wall 66 and increased phospholipid concentrations 65 for several weeks. 67 The lung parenchyma decreased by activation of matrix metalloproteinases. 68 As a result, the fetal lung has a more mature lung structure with more surfactant and better compliance improving gas exchange. The effects of early-response proinflammatory cytokines such as TNF-a, 69 IL-6 and IL-8 56 on pulmonary inflammation were minimal. Inflammation is, however, essential for the induction of the lung maturational changes, which was shown by the fetal administration of an antibody against CD18 blocking the recruitment of inflammatory cells into the airways. 70 The lung inflammation could be induced by LPS from periodontal organisms, 71 but a synthetic agonist for Toll-like receptor (TLR)-2 did not cause a consistent fetal lung inflammation. 72 Intraamniotic injections of endotoxin at 60 to 80 days of gestational age (40 to 55% of gestation) resulted in fetal lung inflammation at 125 days (term 150 days). 73 The experimental sheep work therefore suggests that the immature fetus can mount inflammation after exposure to some proinflammatory stimuli, with subsequent structural changes suggestive of lung maturation. However, the alveolarization of these fetuses was reduced similar to the mild phenotype of BPD, showing that the alveolar development can be intrauterinely impaired by inflammation. 66 The number of alveoli decreases with an increase in individual size, indicating alveolar simplification. The simplification is, however, not limited to the alveoli. Within 2 days of intra-amniotic injection of LPS, endothelial nitric oxide synthase decreased and LPS-induced cytokines known to inhibit vascular development such as interferon-g-inducible protein 10 and transforming growth factor-b increased. 74, 75 Growth factors for vascular development, such as vascular endothelial growth factor and its receptors, rapidly decreased after the initiation of fetal pulmonary inflammation. 74 Most interestingly, the intra-amniotic injection of IL-1a did not cause alveolar or vascular abnormalities, as shown in LPS, but lung maturation. 76 The central question for the fetus remains how the naive innate immune system of the fetus actively controls the inflammation and injury. 77 Animal experimental evidence: immunomodulation. Although the fetus can initiate an inflammatory response at early gestation to LPS, the response is not mature as fetal sheep mounted no response to TNF-a and TLR agonists. We learned that the intra-amniotic endotoxin exposure induced parallel responses of maturation and tolerance in the innate immune system. The fetal lung has virtually no alveolar macrophages or interstitial monocytes until late in gestation. 78 In addition, the monocytes from the fetal lung show little to no response to endotoxin or TNF-a in cytokine or reactive oxygen species production, which is in line with monocyte immaturity. 78 The administration of intra-amniotic LPS induced the cascade of maturation of alveolar macrophages in the fetal lung with expression of granulocyte-macrophage colony-stimulating factor and the expression of transcription factor PU.1 in the monocytes. in vitro to LPS and TNF-a. The response in vitro is comparable to the response of alveolar macrophages from adult sheep. Intra-amniotic endotoxin induced a maturation of immature monocytes to alveolar macrophages that populate the airspace and are responsive to TLR agonists. 79, 80 We then asked whether a second intra-amniotic LPS administration would amplify the fetal inflammatory response. 81 There was no increase in proinflammatory cytokine mRNA or in cell numbers after a second administration of LPS in vivo. The lung monocytes/macrophages did not respond to an additional stimulus with endotoxin or other proinflammatory stimuli in vitro either. [81] [82] [83] The fetal cells became mature and LPS tolerant in a simultaneous way. The tolerance was not limited to the inducing proinflammatory stimuli of LPS, but comprised other TLR agonists as well. 82 The inertness of the inflammatory response may be essential for fetal survival in a proinflammatory environment such as chorioamnionitis. 77 The molecular mechanisms and the clinical implications are just beginning to be studied and understood.
Cardiovascular system
A possible mechanism through which chorioamnionitis may predispose to adverse neurological outcome is cardiovascular instability. However, human reports of postnatal markers of circulatory disturbance have been inconsistent. Associations between chorioamnionitis and decreased blood pressure, 84 occurrence of hypotension 85 and increased use of supportive therapy have all been described. 86 Moreover, umbilical cord levels of IL-6 have been shown to correlate inversely with postnatal blood pressure in chorioamnionitis-exposed infants. 84 However, other studies have failed to reproduce these findings. 87 In a large cohort, we have recently shown that the tendency toward lower blood pressure after chorioamnionitis is explained by the presence of confounding factors such as gestational age or antenatal steroids. 88 Moreover, we were unable to show a relationship between chorioamnionitis and postnatal hypotension or use of supportive therapy. 88 Although at this stage clinical studies are not conclusive regarding the association between antenatal inflammation and postnatal circulatory disturbance, animal studies clearly show cardiovascular instability in utero after exposure to proinflammatory stimuli. In pregnant ewes, intravenous administration of LPS induced placental hypoperfusion, causing chronic hypoxemia, moderate acidemia and cardiotocography changes. 89, 90 Subsequently, a pulmonary hyperperfusion and a decrease in cerebral oxygen transport developed. The latter correlated with an inflammatory reaction of the subcortical regions and periventricular white matter similar to that observed in premature newborns below 1500 g birth weight after intrauterine infection. 17, 19 Taken together, current evidence suggests that intrauterine exposure to inflammation may cause postnatal circulatory disturbance and may thus contribute to the development of brain injury in the preterm newborn.
Sepsis
Many studies have identified both clinical and histological chorioamnionitis as independent risk factors for early-onset sepsis. 8, 59, [91] [92] [93] The association seems to be augmented by additional prolonged presence of PPROM. 91 These observations are not surprising given the alleged infectious etiology of chorioamnionitis. Less straightforward is the clinical observation that the association with early-onset sepsis seems strongest when additional fetal signs of inflammation are absent. 8, 59, 92, 94 Increased use of maternal antibiotics in cases with fetal inflammation could explain part of this association. We tested this hypothesis in a cohort previously described, in which chorioamnionitis without fetal involvement was associated with early-onset sepsis. Addition of maternal administration of antibiotics as a covariate to the original model resulted in a reduction of significance from P ¼ 0.04 to 0.06 of the association between chorioamnionitis without fetal involvement and early-onset sepsis, although administration of maternal antibiotics itself was not a significant factor ( Table 1) . The implication of this finding is very intriguing. This may suggest that part of this previously reported association may be because of the less use of antibiotics when compared with chorioamnionitis-exposed infants with fetal involvement. However, a clear trend toward increased risk of early-onset sepsis remained for infants without fetal involvement, warranting the need for additional studies to resolve this issue. This is, in particular, needed as animal experiments with LPS-induced chorioamnionitis have revealed a profound effect on the local and systemic innate immune system of fetuses. A single exposure matured the fetal immune system with respect to secondary stimuli such as LPS or TNF-a. Repetitive injections induced a paralysis of the fetal immune system that may be a risk factor for subsequent sepsis. [81] [82] [83] Adrenal glands Chorioamnionitis has been shown to be associated with an increase in serum cortisol levels after birth in infants not exposed to antenatal steroids. 95, 96 Similarly, increased adrenal gland volume and a correlation between fetal plasma cortisol and IL-6 levels have been observed after chorioamnionitis 97, 98 ( Figure 1 ). Additional analyses suggested an association between cortisol levels and shorter time to delivery. 98 Together, these data indicate that chorioamnionitis elicits a stress response in the fetus that may contribute to the initiation of preterm delivery. Moreover, given the important role of steroid hormones in lung maturation, this may be one of the mechanisms responsible for the reduction in RDS observed after intrauterine inflammation. 47 
Liver
The liver is part of the fetal hematopoiesis that is mostly extramedullar during the last trimester of gestation. Fetal liver granulopoiesis is, however, at a very low level within the sinusoids, but an early and substantial increase can be observed during infection. 99 Thus, Pfisterer et al. 100 and Stallmach and Karolyi 101 described these morphologic alterations in fetal liver to be helpful in the diagnosis of chorioamnionitis. 100, 101 We found in an animal model of sheep that chorioamnionitis can induce the transcription of acute-phase response genes in the fetal liver. 102 The liver seems to be involved in the initiation and response to chorioamnionitis beyond reactions to hematopoiesis.
Intestines
Necrotizing enterocolitits is a serious and dreaded complication of prematurity. Recently, the development of spontaneous intestinal perforation and necrotizing enterocolitits has been associated with FIRS, of which the mechanisms remain unclear 59, 103 ( Figure 1 ). The pathogenesis is considered to be multifactorial, in which impaired gut barrier function and immune dysfunction have a major role. 104 In the animal model, our research group showed that both prematurity and inflammation in utero affect the maturation of the fetal gut predisposing to postnatal intestinal pathology. To prove our hypothesis, the distributions of the tight junctional protein zonula occludens protein 1 (ZO-1) expression, as well as TLR-4, MD-2 mRNA, myeloperoxidase the expressing cells, T lymphocytes and gd T cells were assessed. Furthermore, contractility of third-generation mesenteric arteries in the absence and presence of nitric oxide and the endothelial nitric oxide synthase expression were studied. This study shows that bacterial toxins impair maturation of tight junctions during gestation. A poor tight junctional distribution suggests an easy access of microbial toxins to the mucosa and the inner layers of the gut ante-and postnatally. We summarized that both prematurity and chorioamnionitis are associated with impaired development of the intestinal innate immune defense, the mucosal barrier and the vascular function. Although these developmental disorders are all related to neonatal intestinal pathology and necrotizing enterocolitits, the clinical effect can only be estimated. 59, 103 The immature gut of preterm babies is a risk factor on its own, which is further aggravated by the presence of antenatal inflammation induced by endotoxin. 105 
Skin
Recently Kim et al. 106 observed leukocytic infiltrates into the superficial dermis in newborn infants exposed to chorioamnionitis with increased expression of TLR-2 and TLR-4. TLRs recognize microbial products and initiate an immune response. Thus, their group showed for the first time that fetal dermatitis can be detected and is part of chorioamnionitis. 106 
Summary and perspective
The outlined clinical, epidemiological and experimental data point to the central role of antenatal fetal infection in the pathogenesis of chronic lung disease, brain damage and various multiorgan alterations (Figure 1 ). Inflammation-associated changes in organ function are complex (Figure 2 ). The short-term benefits may have detrimental long-term effects. The role of the immune system, which is induced and which modulates and exerts the inflammatory response and which may be detrimental on its own, needs further study. This is particularly true as the available clinical data do not point to a single intervention (Figure 2 ). For example, the available data on antibiotic treatment in the ORACLE trials have to be considered with caution, as the treatment with erythromycin is known to yield insufficient concentrations in the fetus. [107] [108] [109] Therefore, new trials with adequate antibiotic coverage of the fetus have to be initiated.
In this context, ascending genital tract infections are critically involved. Pathological vaginal flora may induce premature labor and PPROM with the potential for an acute progressive or a chronic indolent chorioamnionitis. With the progress of the infection or inflammation, a fetal systemic inflammatory reaction may develop. This is typically documented by funitis or funisitis Estimated ORs based on multiple logistic regression models for prediction of early-onset sepsis.
in the histological examination or in the serum. When chorioamnionitis induces a systemic inflammatory reaction in the pregnant woman, a clinical chorioamnionitis with maternal fever and elevated inflammation protein markers in the maternal compartment develops. On the other hand, detection of a funisitis describes a fetal inflammatory reaction that can be documented biochemically through inflammation markers in the fetal or neonatal serum. Here it is of pivotal significance that a dramatic increase in fetal or neonatal morbidity takes place with a fetal inflammatory reaction as opposed to a primarily maternal inflammation with a chorioamnionitis. Many organs of the fetus may be affected under these circumstances turning chorioamnionitis into a 'multi-organ disease' of the fetus. The clinical treatment in this context is far from being optimal. Data analysis, which is stratified according to the presence of chorioamnionitis and/or funisitis, needs to be carried out and subsequent studies should take the histology into account. In future, the characterization of the fetal inflammatory response will have a crucial effect on performing adequate interventions to lower the incidence of perinatally the morbidity and mortality of affected children.
